15 preguntas y respuestas sobre la demencia y el deterioro cognitivo

15 preguntas y respuestas sobre la demencia y el deterioro cognitivo

Dementia is a collective term for a decline in mental ability affecting memory, thinking, behavior, and emotion severely enough to interfere with daily life.

Dementia represents a cluster of symptoms and should not as such be considered a disease.

One of the main challenges facing health professionals diagnosing and treating patients with dementia is to define the underlying cause or disease responsible for the patient’s symptoms. In fact, more than one hundred conditions may cause dementia. Alzheimer disease is the most common cause accounting for 60-70% of all cases.

Dementia ranges in severity. The mildest stage may be recognized by slight changes in thinking, remembering, and reasoning, whereas in the most severe stage, the patient must depend on the help of others for basic activities of living.

Although dementia becomes more common as people age, it should not be considered a normal part of aging. Many people live into their 90s and beyond without any signs of dementia.

deterioro cognitivo

Due to the aging of the population, the burden of dementia is increasing worldwide.

1. ¿Qué tan común es la demencia?

Today, more people than before live longer and healthier lives. Hence, the world population has a higher proportion of older people. The fastest growth in the elderly population is taking place in China, India, and the southwestern part of Asia.

Worldwide, around 50 million people have dementia. Every year, there are nearly 10 million new cases.

The estimated proportion of the general population aged 60 and over with dementia is between 5-8%.

The total number of people with dementia is estimated to reach 82 million in 2030 and 152 million in 2050. Much of this increase is attributable to the increasing numbers of people with dementia living in low- and middle-income countries. Currently, 58% of people with dementia live in these countries. By 2050 this number will have risen to 68%.

Worldwide, around 50 million people have dementia. This number is estimated to reach 82 million in 2030 and 152 million in 2050. Much of this increase is attributable to the increasing numbers of people with dementia living in low- and middle-income countries.

How Common Is Dementia

2. ¿Cuáles son los síntomas más comunes de la demencia?

Dementia affects people differently, causing a considerable variation in symptoms between individuals.

Because of the gradual onset of symptoms, the early stage is often overlooked. Declining memory, especially short-term memory, is the most common early symptom. Other common symptoms include difficulties completing familiar tasks, losing track of time, and becoming lost in familiar places.

Interestingly, most patients with dementia do not by themselves complain of memory loss. It is often a spouse or another close relative who raises a concern.

During the middle stage of dementia (mid-stage dementia) memory loss usually worsens further. The patient may become less aware of time and place and can have difficulties recognizing relatives and friends. Behavior changes, including aggression, often become more pronounced. The patient may become anxious, suspicious, irritable, and agitated. Some patients may even become depressed or apathetic. Often there are difficulties with language, and finding the right words may become difficult.

Sometimes passiveness is pronounced. The patient may sit in front of the television for hours, sleep more than usual, or appear to lose interest in hobbies.

During the late stage of dementia memory impairment becomes more pronounced and loss of insight increases. Behavioral disturbances become more frequent and wandering is common. Those with relatively preserved insight are more likely to be depressed whereas those with more impaired insight are more likely to be agitated. Sleep disturbances are common.

The patients lose the ability to respond to their environment. They also have increasing difficulty communicating and become vulnerable to infections, especially pneumonia. Activities of daily life become more difficult and eventually they may need round-the-clock assistance.

Memory loss that disrupts daily life is the most common symptom of dementia. Other symptoms include difficulties in reasoning and performing complex tasks. Behavioral problems may include anxiety, agitation, and sometimes, depression. At the late stage, help is usually needed with personal care.

3. ¿Cuáles son los tipos más comunes de demencia?

There are many different types of dementia. Alzheimer disease is the most common form of dementia and may contribute to 60–70% of cases.

Other major forms include vascular dementia, dementia with Lewy bodies (abnormal aggregates of protein that develop inside nerve cells), and a group of diseases that contribute to frontotemporal dementia (degeneration of the frontal lobe of the brain).

The boundaries between different forms of dementia are often unclear, and mixed typesexist. The term mixed dementia used to describe a combination of two or more types of dementia.

Alzheimer disease is the most common cause of dementia contributing to 60–70% of cases. Other major forms include vascular dementia, dementia with Lewy bodies, and frontotemporal dementia. Mixed forms often exist.

4. ¿Qué es la enfermedad de Alzheimer?

The science of Alzheimer’s disease has come a long way since 1906, when a German neurologist and psychiatrist named Dr. Alois Alzheimer first described the key features of the disease. Dr. Alzheimer noticed abnormal deposits in the brain of a 51-year old woman who had dementia.

Alzheimer disease is defined as a neurodegenerative disorder of uncertain cause that primarily affects older adults. It is the most common cause of dementia.

One of the hallmarks of Alzheimer disease is the accumulation of amyloid plaques in the brain. Amyloid is a protein fragment that the body usually produces. In a healthy brain, these protein fragments are broken down and eliminated.

In Alzheimer disease, the amyloid fragments, particularly beta amyloid, accumulate to form hard, insoluble plaques.

One of the hallmarks of Alzheimer disease is the accumulation of amyloid plaques in the brain.

Selective memory impairment is usually the earliest clinical manifestation of the disease.

The diagnosis of Alzheimer disease is based on the patient’s history and tests of memory, problem-solving, attention, and language. Standard medical workup is necessary to assess the general health of the patient and to exclude other causes for the symptoms. Computed tomography (CT), magnetic resonance imaging (MRI), or positron emission tomography (PET) may be performed to support the diagnosis.

What Is Alzheimer Disease

Family history often plays a role. There is a higher risk of Alzheimer’s if a close family member has the disease. Having the ApoE4 genetic variant is one of the most significant risk factors for developing the disease.

Most cases of Alzheimer’s develop late in life, and most patients with the disease are 65 or older.

The risk of developing Alzheimer disease appears to be increased by many factors that affect the heart and blood vessels. These include high blood pressure, atherosclerotic heart disease, stroke, and diabetes.

So, although there’s no definitive way to prevent the disease, not smoking, keeping blood pressure and cholesterol at healthy levels,  regular exercise, maintaining a healthy weight and eating a healthy are all sensible measures.

Alzheimer disease is a progressive disorder, where dementia symptoms gradually worsen over several years. In its early stages, memory loss is mild, but with late-stage Alzheimer disease, individuals lose the ability to carry on a conversation and respond to their environment.

LEER  Pies hinchados y tobillos hinchados - Explicación del edema de la pierna

There is no cure available for Alzheimer disease. Although current treatments cannot stop the disease from progressing, they can temporarily slow the worsening of dementia symptoms and improve quality of life for those affected and their caregivers.

Alzheimer disease is as a neurodegenerative disorder of uncertain cause that primarily affects older adults. Having the ApoE4 genetic variant is one of the most significant risk factors for developing the disease. Having high blood pressure, atherosclerotic heart disease, stroke, and diabetes increase the risk of Alzheimer disease.

5. ¿Qué es la demencia vascular?

Vascular dementia, also called vascular cognitive impairment (VCI), refers to any dementia that is primarily caused by cerebrovascular disease or impaired blood flow to the brain. It is the second most common cause of dementia, only exceeded by Alzheimer disease.

The symptoms of vascular dementia can vary widely, depending on the area of the brain affected by vascular injury. As in Alzheimer disease, memory loss is often pronounced.

Symptoms typical of cerebrovascular disease may often be present. Examples are difficulties with speech or walking and numbness or paralysis of one side of the face or body.

In many cases, a clinically diagnosed stroke appears to initiate the onset of symptoms. Hence the term poststroke dementia.

Multiple small strokes or vascular brain injuries may cause symptoms to occur more gradually.

The risk factors for vascular dementia are the same as those for stroke. Not smoking, keeping blood pressure, blood sugar, and cholesterol within normal limits, healthy eating, exercise, and limiting alcohol consumption are examples of measures that may reduce the risk of vascular dementia.

Vascular dementia refers to any dementia that is primarily caused by cerebrovascular disease or impaired blood flow to the brain. The symptoms of vascular dementia mimic those of Alzheimer disease. The patient with vascular dementia often has a previous history of stroke or other signs of underlying cerebrovascular disease.

6. ¿Qué es la demencia con cuerpos de Lewy (DLB)?

Dementia with Lewy bodies (DLB) may account for 10-15 percent of all cases of dementia. Hence it is a common type of dementia.

The disease is associated with abnormal deposits of a protein called alpha-synuclein in the brain. These deposits, called Lewy bodies, affect chemicals in the brain leading to dementia characterized by problems with thinking, movement, behavior, and mood.

Lewy bodies are also found in the brains of patients with Parkinson disease.

In Parkinson disease, Lewy bodies are mainly found at the base of the brain, whereas in DLB, they tend to be found in the outer layers of the brain.

Diagnosing DLB may be challenging. Initially, the disease is often mistaken for Alzheimer disease. However, as the disease progresses, the patients usually develop symptoms typical of Parkinson disease.

Parkinson disease is usually associated with tremor, stooped posture, slow movement, and shuffling gait.

Furthermore, patients with Parkinson’s disease often develop dementia. Hence, the term Parkinson disease dementia.

Dementia with Lewy bodies (DLB) may account for 10-15 percent of all cases of dementia. The disease is associated with abnormal protein deposits in the brain called Lewy bodies. Patients with DLB usually also develop symptoms typical of Parkinson’s disease.

7. ¿Qué es la demencia frontotemporal (FTD)?

Frontotemporal dementia (FTD) occurs when nerve cells in the frontal and temporal lobes of the brain die, leading to shrinking of these parts of the brain.

Formerly known as Pick’s disease, the name, and classification of FTD has been a topic of discussion for decades.

In fact, FTD is a group of heterogeneous neurodegenerative disorders characterized by noticeable changes in social behavior and personality or problems with language accompanied by degeneration of the frontal and/or temporal lobes.

Frontotemporal dementia (FTD) occurs when nerve cells in the frontal and temporal lobes of the brain die, leading to shrinking of these parts of the brain. FTD is a significant cause of dementia in younger people and is most often diagnosed between the ages of 45 and 65.

FTD is a significant cause of dementia in younger people and is is most often diagnosed between the ages of 45 and 65.

The most common type of FTD is the behavioral variant, which is characterized by changes in personality and behavior.

Patients with the behavioral variant of FTD often lose their inhibitions and behave in socially inappropriate ways. They often lose interest and motivation and may show less sympathy or empathy. Their behavior may become repetitive, compulsive, and ritualized.

What Is Frontotemporal Dementia

There may even be altered food preferences, such as carbohydrate cravings, particularly for sweet foods, and binge eating. Increased consumption of alcohol or tobacco may occur.

Sometimes motor neurone disease (MND) may precede or follow the development of the behavioral variant FTD.

Primary progressive aphasia (PPA) is another clinical subtype of FTD.  In PPA, the early symptoms are dominated by difficulties with language that progressively get worse. These are manifested by deficits in word-finding, word usage, word comprehension, or sentence construction.

Three variants of PPA have been described based on the type of language impairment: nonfluent, semantic, and logopenic.

As FTD progresses, brain damage bends to become more widespread. As a result, the symptoms are often similar to those of the later stages of Alzheimer’s disease.

FTD is highly heritable. An autosomal dominant pattern of inheritance is observed in the families of approximately 10 to 25 percent of patients. An additional 40 percent of patients report a family history of dementia or psychiatric conditions.

In frontotemporal dementia (FTD), the frontal and temporal lobes of the brain tend to shrink. The behavioral variant is recognized by loss of inhibition, socially inappropriate behavior, and lack of empathy. Another subtype, primary progressive aphasia (PPA) is characterized by difficulties with language that progressively get worse.

El artículo responde a 15 preguntas importantes sobre el deterioro cognitivo y la demencia. Se discuten los síntomas, los tipos de demencia, la prevención y el tratamiento..

La demencia frontotemporal (FTD) ocurre cuando las células nerviosas en los lóbulos frontales y temporales del cerebro mueren, lo que lleva a la contracción de estas partes del cerebro.

Anteriormente conocida como la enfermedad de Pick, el nombre y la clasificación de FTD ha sido un tema de discusión durante décadas (9).

De hecho, FTD es un grupo de trastornos neurodegenerativos heterogéneos caracterizados por cambios notables en el comportamiento social y la personalidad o problemas con el lenguaje acompañados por la degeneración de los lóbulos frontales y / o temporales (10).

La demencia frontotemporal (FTD) ocurre cuando las células nerviosas en los lóbulos frontales y temporales del cerebro mueren, lo que lleva a la contracción de estas partes del cerebro. FTD es una causa importante de demencia en personas más jóvenes y se diagnostica con mayor frecuencia entre las edades de 45 y 65 años. FTD es una causa significativa de demencia en personas más jóvenes y se diagnostica con mayor frecuencia entre las edades de 45 y 65.

El tipo más común de FTD es la variante conductual, que se caracteriza por cambios en la personalidad y el comportamiento..

Los pacientes con la variante conductual de FTD a menudo pierden sus inhibiciones y se comportan de manera socialmente inapropiada. A menudo pierden interés y motivación y pueden mostrar menos simpatía o empatía. Su comportamiento puede volverse repetitivo, compulsivo y ritualizado (10).

LEER  Ingesta alta en carbohidratos peor que alta en grasas para los lípidos en sangre

Incluso puede haber preferencias alimenticias alteradas, como antojos de carbohidratos, particularmente para alimentos dulces, y atracones. Puede aumentar el consumo de alcohol o tabaco..

A veces, la enfermedad de la neurona motora (EMN) puede preceder o seguir al desarrollo de la variante conductual FTD (11).

La afasia progresiva primaria (PPA) es otro subtipo clínico de FTD. En PPA, los primeros síntomas están dominados por dificultades con el lenguaje que empeoran progresivamente. Estos se manifiestan por déficits en la búsqueda de palabras, uso de palabras, comprensión de palabras o construcción de oraciones (12).

Se han descrito tres variantes de PPA según el tipo de discapacidad del lenguaje: no fluido, semántico y logopénico (13).

A medida que progresa el FTD, el daño cerebral se dobla para generalizarse. Como resultado, los síntomas a menudo son similares a los de las etapas posteriores de la enfermedad de Alzheimer..

FTD es altamente heredable. Se observa un patrón de herencia autosómico dominante en las familias de aproximadamente el 10 al 25 por ciento de los pacientes (12). Un 40 por ciento adicional de pacientes informan antecedentes familiares de demencia o afecciones psiquiátricas..

En la demencia frontotemporal (FTD), los lóbulos frontales y temporales del cerebro tienden a encogerse. La variante conductual se reconoce por la pérdida de inhibición, el comportamiento socialmente inapropiado y la falta de empatía. Otro subtipo, la afasia progresiva primaria (PPA) se caracteriza por dificultades con el lenguaje que empeoran progresivamente.

8. ¿Cómo se identifica la causa de la demencia?

El primer paso al evaluar a los pacientes con sospecha de demencia es determinar si está presente o no. Varios trastornos pueden causar síntomas que imitan la demencia, y estos deben ser excluidos. Por lo tanto, se debe realizar una evaluación médica exhaustiva del paciente en la primera visita.

Las pruebas cognitivas y de comportamiento son el primer paso para evaluar si hay demencia. Estas pruebas se pueden dividir en tres niveles de rigor: herramientas de detección como el Mini examen del estado mental (MMSE), un examen extendido del estado mental y pruebas neuropsicológicas formales (3).

Sin embargo, aunque estas pruebas ayudan a evaluar la cantidad de discapacidad, un historial detallado del paciente, incluida una entrevista con un cónyuge u otro pariente cercano, es de vital importancia.

El historial de drogas es particularmente importante ya que muchas drogas pueden afectar la cognición.

Todos los pacientes deben ser examinados para detectar depresión. El deterioro cognitivo a veces puede ser una característica clave de la depresión. Además, la depresión a menudo puede empeorar el deterioro cognitivo en pacientes con demencia..

Se debe realizar una detección de deficiencia de B12 e hipotiroidismo..

La neuroimagen con tomografía computarizada (CT) o resonancia magnética (MR) puede ser útil. En la mayoría de los casos, se prefiere la RM sobre la TC.

El uso de la tomografía por emisión de positrones (PET) y la tomografía computarizada por emisión de un solo fotón (SPECT) es un área de evaluación continua.

Los síntomas de la enfermedad de Parkinson pueden sugerir demencia con cuerpos de Lewy (DLB). Las anormalidades conductuales y el cambio de personalidad en un paciente relativamente joven pueden sugerir el subtipo conductual de demencia frontotemporal (FTD). Las dificultades del lenguaje fuera de proporción con el deterioro de la memoria sugieren afasia progresiva primaria (PPA).

El historial del paciente y un examen médico completo es el primer paso para evaluar si la demencia está presente o no. Las pruebas cognitivas y de comportamiento ayudan a determinar el grado de deterioro cognitivo. La detección de depresión, deficiencia de vitamina B12 e hipotiroidismo es esencial. La neuroimagen con tomografía computarizada (TC) o resonancia magnética (MR) generalmente se realiza.

9. ¿Qué condiciones pueden imitar la demencia?

El envejecimiento está asociado con el deterioro cognitivo, que generalmente consiste en cambios leves en la memoria y la tasa de procesamiento de la información.

La mayoría de nosotros nos volvemos más olvidadizos a medida que envejecemos. A veces podemos tener dificultades para recordar nombres o poner una firma en la cara, y puede llevar un poco más de tiempo encontrar la palabra correcta. Es posible que nos distraigamos más fácilmente o luchemos para realizar múltiples tareas tan bien como lo hicimos una vez..

Estos cambios son normales, pero pueden ser una molestia y, a veces, frustrantes. A muchas personas les preocupa que estas cosas sean un signo temprano de demencia.

Sin embargo, estos déficits no tienden a ser rápidamente progresivos, ni afectan la función diaria como lo harían si hubiera demencia..

Las deficiencias nutricionales, los efectos secundarios de los medicamentos y la angustia emocional pueden producir síntomas que pueden confundirse con signos tempranos de demencia. Estos pueden incluir problemas de memoria y cambios de comportamiento..

Los pacientes con depresión a menudo muestran signos de deterioro cognitivo que pueden simular demencia. La pérdida de memoria y la incapacidad para concentrarse o concentrarse pueden ser pronunciadas. La memoria de trabajo, la fluidez y las habilidades de planificación y resolución de problemas pueden verse afectadas (14).

Algunas drogas pueden interferir con la función cognitiva y causar síntomas que pueden simular demencia.

Aunque el envejecimiento normal está asociado con el deterioro cognitivo, no tiende a ser rápidamente progresivo y generalmente no afecta la función diaria. Los pacientes con depresión a menudo muestran signos de deterioro cognitivo. Algunas drogas pueden interferir con la función cognitiva y causar síntomas que pueden simular demencia.

10. ¿Pueden las drogas causar deterioro cognitivo que imita la demencia? Sí, pueden.

Las drogas anticolinérgicas, en particular, pueden afectar negativamente la función cognitiva. Estos incluyen medicamentos como tolterodina, a menudo utilizados para tratar la incontinencia urinaria, algunos antidepresivos, antipsicóticos, algunos medicamentos para el corazón, antiespasmódicos, medicamentos antivertigo y medicamentos antiparkinsonianos (15).

Un estudio reciente incluso mostró que la exposición a varios tipos de fármacos anticolinérgicos potentes se asocia con un mayor riesgo de demencia (16).

Las benzodiazepinas, una clase de medicamentos utilizados para tratar la ansiedad o el insomnio, comprenden otro grupo que se ha relacionado con dificultades cognitivas..

Se sospecha que las estatinas para reducir el colesterol que se usan con frecuencia crean dificultades de memoria y desaceleración mental en algunas personas. Sin embargo, todavía hay opiniones divididas sobre este tema..

Se han documentado cambios cognitivos asociados con los agentes quimioterapéuticos utilizados para tratar el cáncer. La afección se denomina comúnmente «cerebro de quimioterapia» o «niebla de quimioterapia», aunque es poco probable que la quimioterapia sea la única causa de estos problemas cognitivos (17). La duración de la quimioterapia cerebral puede variar desde unas pocas semanas hasta varios años..

Los analgésicos, los opioides, en particular, pueden afectar negativamente la memoria a corto plazo.

Varias drogas pueden causar deterioro cognitivo. Por ejemplo, los fármacos anticolinérgicos, algunos medicamentos utilizados para la ansiedad y el insomnio, los agentes quimioterapéuticos utilizados para tratar el cáncer y los fármacos opioides..

11. What Is Mild Cognitive Impairment (MCI)?

Mild cognitive impairment (MCI) refers to cognitive impairment that is not severe enough to meet the criteria for dementia.

MCI is not an established diagnosis but refers to the transitional zone between normal aging and dementia. Although individuals with MCI have impaired cognitive function in specific domains, it is not severe enough to interfere with daily life.

However, it may be quite challenging to make the distinction between impairments that are normal for an adult and those that do represent MCI or dementia. What constitutes impairment in daily living is different for each individual.

LEER  Ayuno intermitente y salud - La evidencia científica

MCI is relatively common. One study showed the following numbers for the prevalence of MCI:

  • 6.7% for ages 60-64,
  • 8.4% for 65-69,
  • 10.1% for 70-74,
  • 14.8% for 75-79,
  • 25.2% for 80-84.

The risk of developing dementia in individuals with MCI older than  65 years followed for 2 years was 14.9%. Thus it appears that people with MCI have an increased risk of developing dementia compared to the average population.

Amnestic MCI is the most common subtype of MICI and refers to individuals with significantly impaired memory who do not meet the criteria for dementia. Otherwise, cognitive function is preserved, and activities of daily living are intact.

Amnestic MCI is often regarded as a precursor to Alzheimer disease

Nonamnestic MCI may affect a single domain or multiple domains other than memory. Examples of such domains are executive functioning, language, or visual-spatial skills.

Mild cognitive impairment (MCI) refers to cognitive impairment that is not severe enough to meet the criteria for dementia. People with MCI have an increased risk of developing dementia compared to the average population. Amnestic MCI is often regarded as a precursor to Alzheimer disease.

Low physical, mental and social activity appears to be associated with an increased risk of dementia

12. What Are the Risk Factors For Dementia?

Age is the strongest risk factor for dementia. The risk of Alzheimer disease increases rapidly after the age of 60 years. Overall, approximately 85 percent of dementia cases are in adults 75 years of age and older.

Genetic factors play an important role in Alzheimer disease. Parental history of dementia is associated with a twofold increase in the risk of dementia. Risk estimates gradually decline with advancing parental age at diagnosis of dementia.

APOE genotype status is a powerful risk factor for subsequent risk of dementia.

Cardiovascular risk factors are linked to increased risk of dementia. One large study showed that midlife diabetes, hypertension, and smoking are associated with an increased risk of dementia.

In the same study, total cholesterol level was not associated with an increased hazard of dementia. Other lipid fractions were tested in separate models and were not related to the risk of dementia.

Stroke is a risk factor for dementia. Approximately 10 percent of patients develop new-onset dementia after a first stroke, and up to one-third of patients develop dementia after recurrent stroke.

Mild cognitive impairment (MCI) may be considered a risk factor for dementia because it often progresses to dementia.

Diabetes is associated with an approximately 1.5- to 2-fold increase in the relative risk of cognitive decline and dementia later in life.

Studies indicate that midlife obesity increases the risk of dementia later in life.

Obstructive sleep apnea (OSA) has been associated with an increased risk for MCI and dementia. A very large pooled analysis showed that those with sleep-disordered breathing were 26 percent more likely to develop clinically relevant cognitive decline or dementia.

Low physical, mental, and social activity appears to be associated with an increased risk of dementia. Because these are all are modifiable factors, they may present options for decreasing the risk of cognitive decline and dementia.

Lower levels of education are associated with an increased risk of dementia.

Alcohol abuse is associated with increased risk of cognitive decline and dementia.

Age is the strongest risk factor for dementia. Genetic factors are also important. Other risk factors include diabetes, hypertension, smoking, obesity, alcohol abuse, and history of stroke. Social isolation and low physical and mental inactivity are also associated with increased risk of dementia.

13. How Is Dementia Treated?

It is true for almost all of the diseases causing dementia that they cannot be cured.

Non-drug treatments of dementia mainly play a supportive role.

Cognitive rehabilitation aims to help patients in the early stages of dementia to maintain memory and cognitive function.

There is promising evidence that exercise programs may improve the ability to perform activities of daily life in people with dementia.

Other popular activities include music, singing, or art. It is vital that people with dementia stay as active as they can, physically, mentally, and socially. Taking part in meaningful activities is enjoyable and leads to increased confidence and self-esteem .

There are drugs available that may reduce the symptoms of dementia and possibly halt progression for a while. Cholinesterase inhibitors such as donepezil, rivastigmine, and galantamine are frequently used for this purpose. These drugs appear to provide modest symptomatic benefit in some patients with dementia.

Memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist. The drug which may protect brain cells and appears to have modest benefits in patients with moderate to severe Alzheimer disease.There is little, if any, evidence that patients with milder disease derive benefit from the drug.

Dementia cannot be cured unless a correctable underlying cayuse is found. Non-drug treatments of dementia mainly play a supportive role. Physical exercise appears to be beneficial. Drugs are available that may provide symptomatic benefits in some patients with dementia.

14. What Is the Prognosis of Patients With Dementia?

Dementia shortens life expectancy. Irrespective of the underlying cause, dementia is a progressive disorder.

The rate of progression for Alzheimer disease varies widely. The average life expectancy after the disease is diagnosed  has been reported to be between 8 and 10 years but may range from 3 to 20 years. The degree of impairment at diagnosis will affect life expectancy.

The average life expectancy after a the disease is diagnosed has been reported to be between 8 and 10 years but may range from 3 to 20 years.

Older age of onset Alzheimer symptoms is associated with a slower rate of decline compared with younger patients.

Like all other types of degenerative dementia, dementia with Lewy bodies (DLB) is a progressive disorder and associated with a shortened lifespan. Cognitive impairment and Parkinson symptoms both tend to worsen over time.

In general, the prognosis of DLB is similar to Alzheimer disease. However, in some patients, symptoms may progress faster and slower in others.

Early survival analyses showed median survival from diagnosis of frontotemporal dementia (FTD) to be 7–13 years in clinic cohorts. The behavioral type and primary progressive aphasia (PPA show comparable survival times. Survival is usually worse if concomitant motor neuron disease is present.

Dementia shortens life expectancy. The average life expectancy after Alzheimer disease is diagnosed  has been reported to be between 8 and 10 years but may range from 3 to 20 years.

15. How Can dementia Be Prevented?

Seven modifiable risk factors have been associated with increased risk of Alzheimer disease.

  • Diabetes
  • Midlife hypertension
  • Midlife obesity
  • Depression
  • Physical inactivity
  • Smoking
  • Cognitive inactivity or low educational attainment

It has been estimated that up to half of AD cases are potentially attributable to these modifiable risk factors.

Avoiding these factors may markedly reduce the risk of dementia.

Avoiding diabetes, midlife hypertension, midlife obesity, depression, physical inactivity, smoking, cognitive inactivity, and low educational attainment may markedly reduce the risk of dementia.